Redmile Group

Venture Capital

Healthcare-focused hedge fund and crossover investor backing biotech, therapeutics, and life sciences companies from early stage to public markets.

San Francisco, United States · 55+ investments

Seed
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
Therapeutics
Headquarters
San Francisco, United States
Founded
2007
AUM
$1.4B
Total Investments
55
Last Investment
Feb 2025
Geographic Focus
United States